Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 3/20 | 0.35 |
| ▸ | CNR2 | P34972 | 3/20 | 0.35 |
| ▸ | CHKA | P35790 | 1/20 | 0.32 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
| ▸ | ALOX5AP | P20292 | 3/20 | 0.31 |
| ▸ | FEN1 | P39748 | 3/20 | 0.31 |
| ▸ | TYR | P14679 | 1/20 | 0.31 |
| ▸ | CTSL | P07711 | 1/20 | 0.30 |
| ▸ | CTSS | P25774 | 1/20 | 0.30 |
| ▸ | CTSK | P43235 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13000041 | 0.96 | CNR1 (0.34) | CNR1CNR2CHKAFFAR4 | |
| SCHEMBL13262870 | 0.95 | TYR (0.33) | CNR1CNR2CHKAFFAR4ALOX5AP | |
| SCHEMBL12999901 | 0.92 | CTSL (0.36) | CHKAFFAR4ALOX5APFEN1CTSL | |
| SCHEMBL15495082 | 0.91 | TYR (0.36) | CNR1CNR2TYR | |
| SCHEMBL13000033 | 0.89 | CTSL (0.34) | CHKAALOX5APFEN1CTSLCTSS | |
| SCHEMBL12716382 | 0.89 | FFAR4 (0.37) | CHKAFFAR4CTSLCTSSCTSK | |
| SCHEMBL12733846 | 0.89 | CHKA (0.36) | CHKAFFAR4ALOX5APFEN1 | |
| SCHEMBL8934874 | 0.88 | CYP2C9 (0.32) | CHKAFFAR4ALOX5APFEN1 | |
| SCHEMBL12999896 | 0.87 | CHKA (0.34) | CHKAFFAR4ALOX5APFEN1 | |
| SCHEMBL8934922 | 0.87 | GAA (0.35) | CHKAFFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100309402-A1 | FOUR- OR FIVE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | CHISSO CORPORATION (JP) | 2010-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100309402-A1 | FOUR- OR FIVE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | KIF23, HCN3, FZD7 | CNR1 2494/4885CNR2 2017/4885CHKA 1530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.